GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cd44 | decreases expression | EXP | | 6480464 | CTD | Acetaminophen results in decreased expression of CD44 mRNA | PMID:23358195 | Cd44 | increases expression | EXP | | 6480464 | CTD | Acetaminophen results in increased expression of CD44 mRNA | PMID:34724096 | Cd44 | increases response to substance | EXP | | 6480464 | CTD | CD44 gene polymorphism results in increased susceptibility to Acetaminophen; CD44 polymorphism results in increased susceptibility to Acetaminophen | PMID:19416960 PMID:22940726 | Cd44 | affects expression | ISO | CD44 (Homo sapiens) | 6480464 | CTD | Acetaminophen affects the expression of CD44 mRNA | PMID:25458485 | Cd44 | increases expression | ISO | Cd44 (Rattus norvegicus) | 6480464 | CTD | Acetaminophen results in increased expression of CD44 mRNA | PMID:33387578 | Cd44 | increases expression | ISO | CD44 (Homo sapiens) | 6480464 | CTD | Acetaminophen results in increased expression of CD44 mRNA | PMID:27761495 PMID:29067470 | Cd44 | increases response to substance | ISO | CD44 (Homo sapiens) | 6480464 | CTD | CD44 gene polymorphism results in increased susceptibility to Acetaminophen | PMID:19416960 | Cd44 | multiple interactions | ISO | Cd44 (Rattus norvegicus) | 6480464 | CTD | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CD44 mRNA | PMID:25607892 | |
Go Back to source page | Continue to Ontology report |